Before taking Datroway(DatopotamabDeruxtecan-dlnk)

Key warnings and precautions for safe use of DATROWAY are highlighted here.

Warnings and Precautions

Patients should be monitored for interstitial lung disease/pneumonitis, with prompt corticosteroid initiation if suspected. Ocular adverse reactions, such as dry eye and keratitis, require regular eye exams and prophylactic lubricating eye drops. Stomatitis management includes steroid mouthwash and oral ice during infusion. DATROWAY can cause embryo-fetal harm, so effective contraception is advised for females and males during and after treatment. Breastfeeding is not recommended during therapy and for one month after the last dose.

DatopotamabDeruxtecan-dlnk(Datroway)
Treatment of unresectable or metastatic HR-positive, HER2-negative breast cancer in adults who have received prior endocrine therapy and chemotherapy.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved